Susceptibility analysis of mutations that confer resistance to inhibitors of the main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) of the SARS-CoV-2 virus

Enormous efforts have been made worldwide to generate therapeutic options to prevent the transmissibility of the SARS-CoV-2 and reduce its replication in humans. Currently, the emergence of new variants of the virus is of great concern because the evolution of the viral genome and the inherent mutat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Espín-Sánchez, Daysi (author)
Otros Autores:	Vizuete-Rubio, Carolina (author), Jaramillo-Guapisaca, karen (author), Ramos-Aristimbay, María (author), Sánchez-Vaca, Andrés (author), Chico-Terán, Fernanda (author), Cerda-Mejía, Liliana (author), García, Mario (author)
Formato:	article
Lenguaje:	spa
Publicado:	2022
Materias:	SARS-CoV-2, Mpro, RdRp, homología, mutaciones, docking. SARS-CoV-2, Mpro, RdRp, homology, mutations, docking.
Acceso en línea:	https://revistas.uta.edu.ec/erevista/index.php/aci/article/view/1845
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Susceptibility analysis of mutations that confer resistance to inhibitors of the main protease (Mpro) and RNA-dependent RNA polymerase (RdRp) of the SARS-CoV-2 virus

Ejemplares similares